MeMed, a medtech company focused on translating the immune system’s complex signals into simple insights that transform how diseases are diagnosed and treated, today announced that FDA has granted ...
Proteins in saliva could help predict the severity of a COVID infection in children, according to researchers. A study, which started in January, looks at the relationship between cytokines and COVID ...
FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis
-Major Development Milestone Reinforces MeMed’s Leadership in Host-Response Diagnostics- -FDA Endorsement Accelerates Product Development and Market Readiness- ANDOVER, Mass. & HAIFA, Israel–(BUSINESS ...
MeMed has received breakthrough device designation (BDD) from the US Food and Drug Administration (FDA) for its MeMed Severity test, designed to enhance the management of patients with suspected acute ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A blood test at the time of diagnosis can predict the ...
PISCATAWAY, N.J.--(BUSINESS WIRE)-- Today, Infinity BiologiX (IBX) announces the launch of a new test meant to assess the severity of COVID-19 in individuals. The COVID-19 Risk Test is designed to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results